1. Home
  2. AVDX vs NNNN Comparison

AVDX vs NNNN Comparison

Compare AVDX & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDX
  • NNNN
  • Stock Information
  • Founded
  • AVDX 2000
  • NNNN 2021
  • Country
  • AVDX United States
  • NNNN Germany
  • Employees
  • AVDX N/A
  • NNNN N/A
  • Industry
  • AVDX EDP Services
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AVDX Technology
  • NNNN Health Care
  • Exchange
  • AVDX Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • AVDX 2.0B
  • NNNN 2.2B
  • IPO Year
  • AVDX 2021
  • NNNN 2025
  • Fundamental
  • Price
  • AVDX $9.91
  • NNNN $48.56
  • Analyst Decision
  • AVDX Hold
  • NNNN
  • Analyst Count
  • AVDX 14
  • NNNN 0
  • Target Price
  • AVDX $9.73
  • NNNN N/A
  • AVG Volume (30 Days)
  • AVDX 1.6M
  • NNNN 119.3K
  • Earning Date
  • AVDX 08-06-2025
  • NNNN 01-01-0001
  • Dividend Yield
  • AVDX N/A
  • NNNN N/A
  • EPS Growth
  • AVDX N/A
  • NNNN N/A
  • EPS
  • AVDX N/A
  • NNNN 0.06
  • Revenue
  • AVDX $446,722,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • AVDX $5.56
  • NNNN N/A
  • Revenue Next Year
  • AVDX $9.95
  • NNNN N/A
  • P/E Ratio
  • AVDX N/A
  • NNNN $888.24
  • Revenue Growth
  • AVDX 8.04
  • NNNN 21.95
  • 52 Week Low
  • AVDX $6.61
  • NNNN $5.18
  • 52 Week High
  • AVDX $11.68
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • AVDX 73.75
  • NNNN N/A
  • Support Level
  • AVDX $9.85
  • NNNN N/A
  • Resistance Level
  • AVDX $9.88
  • NNNN N/A
  • Average True Range (ATR)
  • AVDX 0.02
  • NNNN 0.00
  • MACD
  • AVDX -0.00
  • NNNN 0.00
  • Stochastic Oscillator
  • AVDX 85.71
  • NNNN 0.00

About AVDX AvidXchange Holdings Inc.

AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: